Cereius, Inc. is a preclinical-stage biotechnology company that develops targeted radiodiagnostics and radiotherapeutics for cancer, with a focus on treating solid tumor brain…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Cereius, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Cereius, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.